11 . 06 .2021
Press release
Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe
19 . 05 .2021
Press release
How Galderma's Environmental, Social and corporate Governance approach guides its roadmap for sustainable growth
11 . 05 .2021
Press release
Galderma launches CETAPHIL® line for sensitive skin and a new DAYLONG® sun protection product in Switzerland
04 . 05 .2021
Press release
Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases
03 . 05 .2021
Press release
Cetaphil® Champions Sun Protection Awareness and Education with Dermatologist-led Digital Campaign
21 . 04 .2021
Press release
#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month
08 . 04 .2021
Press release
Galderma announces publication of phase 2b trial results demonstrating the rapid and long-lasting benefits of nemolizumab in clinical trial subjects with uncontrolled atopic dermatitis